134
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Gas6 as a Putative Noninvasive Biomarker of Hepatic Fibrosis

, , , , , , , , & show all
Pages 1241-1249 | Received 01 Aug 2016, Accepted 04 Oct 2016, Published online: 07 Dec 2016

References

  • Bataller R , BrennerDA. Liver fibrosis. J. Clin. Invest.115, 209–218 (2005).
  • Friedman SL. Liver fibrosis – from bench to bedside. J. Hepatol.38, S38–S53 (2003).
  • European Association for Study of Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J. Hepatol.60, 392–420 (2014).
  • Neuman MG , CohenLB, NanauR. Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin. Biochem.49, 302–315 (2016).
  • Arena U , VizzuttiF, CortiGet al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology47, 380–384 (2008).
  • Manfioletti G , BrancoliniC, AvanziG, SchneiderC. The protein encoded by a growth arrest-specific gene (Gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell Biol.13, 4976–4985 (1993).
  • Varnum BC , YoungC, ElliottGet al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature373, 623–626 (1995).
  • Godowski PJ , MarkMR, ChenJ, SadickMD, RaabH, HammondsRG. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell82, 355–358 (1995).
  • Alciato F , SainaghiPP, SolaD, CastelloL, AvanziGC. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J. Leukoc. Biol.87, 869–875 (2010).
  • Lu Q , LemkeG. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science293, 306–311 (2001).
  • Yanagita M , AraiH, IshiiKet al. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am. J. Pathol.158, 1423–1432 (2001).
  • Lafdil F , ChobertMN, CouchieDet al. Induction of Gas6 protein in CCl4-induced rat liver injury and anti-apoptotic effect on hepatic stellate cells. Hepatology44, 228–239 (2006).
  • Sandrin L , FourquetB, HasquenophJMet al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound. Med. Biol.29, 1705–1713 (2003).
  • Ishak K , BaptistaA, BianchiLet al. Histologic grading and staging of chronic hepatitis. J. Hepatol.24, 289–293 (1995).
  • Tarantino G , CitroV, ConcaPet al. What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol. 9, 89 (2009).
  • Alciato F , SainaghiPP, CastelloL, BergamascoL, CarnielettoS, AvanziGC. Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma. J. Immunoassay Immunochem.29, 167–180 (2008).
  • Food and Drug Administration, US Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Guidance for industry: bioanalytical method validation. 1–20 (2001). www.fda.gov/cder/guidance/index.htm
  • Sainaghi PP , CollimedagliaL, AlciatoFet al. Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J. Neurol. Sci.269, 138–142 (2008).
  • Sainaghi PP , AlciatoF, CarnielettoSet al. Gas6 evaluation in patients with acute dyspnea due to suspected pulmonary embolism. Respir. Med.103, 589–594 (2009).
  • Sainaghi PP , CollimedagliaL, AlciatoFet al. Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis. Mediators Inflamm.2013, 406483 (2013).
  • Bárcena C , StefanovicM, TutusausAet al. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J. Hepatol.63, 670–678 (2015).
  • Fourcot A , CouchieD, ChobertMNet al. Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol.300, G1043–G1053 (2011).
  • Standish RA , CholongitasE, DhillonA, BurroughsAK, DhillonAP. An appraisal of the histopathological assessment of liver fibrosis. Gut55, 569–578 (2006).
  • Narimatsu H. Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics. Expert Rev. Proteomics12, 683–693 (2015).
  • Lee HJ , JengYM, ChenYL, ChungL, YuanRH. Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma. Carcinogenesis35, 769–775 (2014).
  • Chang PE , GohGB, NguJH, TanHK, TanCK. Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J. Gastrointest. Pharmacol. Ther.7, 91–106 (2016).
  • Petta S , ValentiL, MarraFet al. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease. J. Hepatol.64, 682–690 (2016).
  • Marí M , TutusausA, García de FrutosP, MoralesA. Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis. J. Hepatol.64, 983–984 (2016).
  • Ballantine L , MidgleyA, HarrisD, RichardsE, BurgessS, BeresfordMW. Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus. Pediatr. Rheumatol. Online J.13, 10 (2015).
  • Weinger JG , OmariKM, MarsdenK, RaineCS, Shafit-ZagardoB. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Am. J. Pathol.175, 283–293 (2009).
  • Llacuna L , BárcenaC, Bellido-MartínLet al. Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury. Hepatology52, 1371–1379 (2010).
  • Lafdil F , ChobertMN, DeveauxVet al. Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice. J. Hepatol.51, 55–66 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.